![](/img/cover-not-exists.png)
HER3 targeting with an antibodyâdrug conjugate bypasses resistance to antiâHER2 therapies
GandulloâSánchez, LucÃa, Capone, Emily, Ocaña, Alberto, Iacobelli, Stefano, Sala, Gianluca, Pandiella, AtanasioVolume:
12
Journal:
EMBO Molecular Medicine
DOI:
10.15252/emmm.201911498
Date:
May, 2020
File:
PDF, 3.31 MB
2020